No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antimetabolites, Antineoplastic / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cytarabine* / therapeutic use
-
Glucose Transporter Type 1 / genetics
-
Humans
-
Leukemia, Myeloid, Acute* / drug therapy
-
Leukemia, Myeloid, Acute* / genetics
Substances
-
Antimetabolites, Antineoplastic
-
Glucose Transporter Type 1
-
Cytarabine
Grant support
Funding: this work was supported by Swedish Research Council (2016-01319 and 2017-05816) and the Swedish Cancer Society (2017/307).